Active, Not Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Gilbert Neurology Gilbert, Arizona, United States
- Xenoscience Phoenix, Arizona, United States
- Banner Alzheimer's Institute Phoenix, Arizona, United States
- Perseverance Research Center Scottsdale, Arizona, United States